METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP:

• Do you, or did you, own shares of Metagenomi, Inc. (NASDAQ: MGX)?
• Did you purchase your shares pursuant and/or traceable to Metagenomi’s registration statement for the initial public offering held between February 9 and 13, 2024?
• Did you lose money in your investment in Metagenomi, Inc.?
• Do you want to discuss your rights?

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors (the “Class”) who purchased or acquired the stock of Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX) pursuant and/or traceable to Metagenomi’s registration statement for the initial public offering held between February 9 and 13, 2024. The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Act of 1933 against the Company and certain of its officers (the “Complaint”).

If you purchased or acquired Metagenomi stock, and/or would like to discuss your legal rights and options please visit Metagenomi, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.

According to the lawsuit, Metagenomi made misrepresentations concerning the Company’s collaboration with Moderna through a Strategic Collaboration and License Agreement, entered into on October 29, 2021, which included multiple four-year research programs and a subsequent licensed product-by-licensed product agreement.

If you wish to serve as lead plaintiff for the Class, you must file papers by November 25, 2024. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2024 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
pallocco@bernlieb.com